Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

KALA BIO, Inc. - Common Stock (NQ:KALA)

2.530 -0.180 (-6.64%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	50,894
Open	2.780
Bid (Size)	2.500 (100)
Ask (Size)	3.000 (3,100)
Prev. Close	2.710
Today's Range	2.520 - 2.800
52wk Range	0.0660 - 20.60
Shares Outstanding	7,432,925
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

InvestorNewsBreaks – KALA BIO, Inc. (NASDAQ: KALA) Implements 1-For-50 Reverse Stock Split

May 08, 2026

Via Investor Brand Network

KALA BIO Announces Reverse Stock Split

May 07, 2026

Common Stock Will Begin Trading on Split-Adjusted Basis on May 11, 2026

From KALA BIO, Inc.

Via GlobeNewswire

Performance

YTD	+307.3%	+307.3%
1 Month	+1165.0%	+1165.0%
3 Month	+535.7%	+535.7%
6 Month	+261.9%	+261.9%
1 Year	-30.5%	-30.5%

More News

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

April 21, 2026

From KALA BIO, Inc.

Via GlobeNewswire

$9.1 Billion Mesenchymal Stem Cell Market by 2031 to be Focused on by New Senior Scientific Advisor for KALA BIO, Inc. (Nasdaq: KALA)

April 17, 2026

Via Get News

Wondering what's happening in today's after-hours session? ↗

April 01, 2026

Via Chartmill

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

April 01, 2026

From KALA BIO, Inc.

Via GlobeNewswire

Bionic Intelligence Research Agent Now Commercially Live for Secure, Scalable, Autonomous Solutions in Global Biotech and Pharma Industries: KALA BIO, Inc. (Nasdaq: KALA)

March 31, 2026

Via Get News

KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

March 30, 2026

From KALA BIO, Inc.

Via GlobeNewswire

$180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA)

March 19, 2026

Via Get News

Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

March 18, 2026

From KALA BIO, Inc.

Via GlobeNewswire

Which stocks have an unusual volume on Friday? ↗

March 13, 2026

Via Chartmill

Which stocks have an unusual volume on Thursday? ↗

March 12, 2026

Via Chartmill

These stocks are making the most noise in today's session. ↗

March 11, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 11, 2026

Via Chartmill

Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents

March 11, 2026

Via Newsfile

What's going on in today's pre-market session ↗

March 11, 2026

Via Chartmill

Why Did KALA Stock Surge 70% In Pre-Market Today? ↗

March 11, 2026

Via Stocktwits

Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates

March 11, 2026

From KALA BIO, Inc.

Via GlobeNewswire

$167 Billion Invested in Biotech R&D is Underserved by AI, Offering Huge Opportunity for New On-Premises AI Infrastructure Platform from KALA BIO, Inc. (Nasdaq: KALA)

March 05, 2026

Via Get News

KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform

March 04, 2026

From KALA BIO, Inc.

Via GlobeNewswire

Get insights into the top gainers and losers of Thursday's after-hours session. ↗

January 08, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

January 05, 2026

Via Chartmill

KALA BIO Settles Approximately $10.6 million of Debt

January 05, 2026

From KALA BIO, Inc.

Via GlobeNewswire

KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

December 05, 2025

From KALA BIO, Inc.

Via GlobeNewswire

Which stocks are most active on Thursday? ↗

December 04, 2025

Via Chartmill

Frequently Asked Questions

Is KALA BIO, Inc. - Common Stock publicly traded?

Yes, KALA BIO, Inc. - Common Stock is publicly traded.

What exchange does KALA BIO, Inc. - Common Stock trade on?

KALA BIO, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for KALA BIO, Inc. - Common Stock?

The ticker symbol for KALA BIO, Inc. - Common Stock is KALA on the Nasdaq Stock Market

What is the current price of KALA BIO, Inc. - Common Stock?

The current price of KALA BIO, Inc. - Common Stock is 2.530

When was KALA BIO, Inc. - Common Stock last traded?

The last trade of KALA BIO, Inc. - Common Stock was at 05/19/26 04:00 PM ET

What is the market capitalization of KALA BIO, Inc. - Common Stock?

The market capitalization of KALA BIO, Inc. - Common Stock is 18.81M

How many shares of KALA BIO, Inc. - Common Stock are outstanding?

KALA BIO, Inc. - Common Stock has 19M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.